SEC Form 4 · accession 0001019687-15-001300
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ruslan Semechkin
Officer — Chief Scientific Officer · Director · 10% Owner
Period of report
Mar 31, 2015
Accepted (ET)
Apr 2, 2015 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2015 | P | 1,861,331 | $0.0448 | A | 9,402,715 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Warrant (Right to Buy) | $0.0448 | Mar 31, 2015 | X | 1,861,331 | D | Oct 14, 2014 | Apr 14, 2015 | Common Stock | 1,861,331 | 0 | D |